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Abstract Prader–Willi syndrome (PWS) is well-known for
its genetic and phenotypic complexities. Caused by a lack
of paternally derived imprinted material on chromosome
15q11–q13, individuals with PWS have mild to moderate
intellectual disabilities, repetitive and compulsive behav-
iors, skin picking, tantrums, irritability, hyperphagia, and
increased risks of obesity. Many individuals also have co-
occurring autism spectrum disorders (ASDs), psychosis,
and mood disorders. Although the PWS 15q11–q13 region
confers risks for autism, relatively few studies have
assessed autism symptoms in PWS or directly compared
social, behavioral, and cognitive functioning across groups
with autism or PWS. This article identifies areas of
phenotypic overlap and difference between PWS and
ASD in core autism symptoms and in such comorbidities
as psychiatric disorders, and dysregulated sleep and eating.
Though future studies are needed, PWS provides a
promising alternative lens into specific symptoms and
comorbidities of autism.
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First described over 50 years ago, Prader–Willi syn-
drome (PWS) is well-known for its genetic and
phenotypic complexities. Seen in approximately one in
10,000 births, PWS is caused by a lack of paternally
derived imprinted material on chromosome 15q11–q13,
either through paternal deletion or maternal uniparental
disomy (mUPD; when both copies of chromosome 15
are maternally inherited). PWS is characterized by mild
to moderate levels of intellectual disability, compulsive
behaviors, skinpicking, tantrums, irritability, hoarding,
heightened fascination and skills with jigsaw and word
search puzzles, growth hormone dysregulation, hyper-
phagia, and increased risks of morbid obesity. Psychosis
and autism spectrum disorders are also commonly seen
(Dykens and Cassidy 2003).
Despite increased genetic understandings of the 15q11–
q13 region (Hogart et al. 2010), PWS remains a life-
threatening and clinically challenging disorder. Manage-
ment challenges in PWS stem from food-seeking behaviors
combined with high rates of social, emotional, and
behavioral dysfunction. Many families find that even though
dietary restrictions and food-seeking behaviors require their
constant attention, food issues pale in comparison to their
child’s tantrums, skin picking, compulsivity, and needs for
sameness (Dykens et al. 2007). While hyperphagia and skin
picking are highly characteristic of PWS, compulsivity and
tantrums are often seen in other developmental disabilities,
including autism spectrum disorders.
This article reviews similarities and differences between
PWS and autism spectrum disorder (ASD), and the
important role that development plays in these compar-
isons. As PWS entails high risks of mood disorders and
psychosis, links to autism may not be as straightforward as
initially thought. While PWS is one of several genetic
disorders associated with autism, this co-occurrence is
much less well-researched than autism in the context of
fragile X, 22q deletion, tuberous sclerosis, Rett, Smith–
Lemi–Optiz, or other genetic conditions (for reviews, see
Betancur 2011; Grafodatskaya et al. 2010). As a group,
however, so-called “syndromic autism” accounts for up to
10% of all cases with autism (e.g., Herman et al. 2007). The
molecular genetic causes and behavioral phenotypes of
these syndromes offer promising alternative windows into
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ASDs (Dykens et al. 2004). Although autism-specific data
in PWS are scant relative to other syndromes, this article
highlights intriguing similarities and differences between
these disorders and promising areas for future research.
PWS and autism: genetic links and prevalence
PWS is caused by a lack of paternally derived imprinted
material on 15q11–q13, while Angelman syndrome (AS),
its oppositely imprinted genetic “sister,” is caused by
disruptions in the maternally expressed ubiquitin-protein
ligase E3A (UBE3A) gene in this same 15q11–q13 region.
PWS and AS are phenotypically distinct: those with AS
have an ataxic gait, severe intellectual disabilities, seizures,
frequent laughter, and limited speech. Together, PWS and
AS made molecular genetic history as the first disorders to
show the effects of parent-of-origin genomic imprinting.
Approximately 70% of PWS cases are due to a paternal
deletion at 15q11–q13. Such deletions can be further
characterized according to size, with type I deletions
(BP3–BP1) being about 500 bp larger than type II deletions
(BP 3–BP2). Chai et al. (2003) identified four non-
imprinted genes that are deleted in type I cases, but present
in those with smaller, type II deletions—cytoplasmic FMR1
interacting protein 1 (CYFIP1), NIPA1, NIPA2, and GCP5.
At least 10% of deletion cases have unique breakpoints that
are only now being identified through high-resolution array
and other techniques (Kim et al. 2007), and these
individuals may ultimately facilitate genotype–phenotype
linkages. About 25% of PWS cases are due to mUPD or
when both copies of chromosome 15 are maternally
inherited and 5% of cases to translocations or imprinting
center mutations.
The PWS critical region includes a small nucleolar RNA
(snoRNA) and HBII-52 (SNORD115), which has been
shown to regulate the processing of the mRNA of the
serotonin 2 C receptor, located elsewhere on the genome
(Kishore and Stamm 2006). New mouse models of PWS
are based on this finding, including mice deleted for HBII-
52 (Ding et al. 2008) or with altered 2 C receptor mRNA
functioning (Morabito et al. 2010). As with other PWS
models, these mice are hyperphagic but not obese. Sahoo et
al. (2008) reported a boy with features consistent with the
diagnosis of PWS who had a small deletion of only the
snoRNA HBII-85 and part of SNORD115 region, strongly
implicating these clusters in the PWS phenotype. Lack of
HBII-52 expression in PWS may lead to altered processing
of serotonin 2 C receptor mRNA, which may impact the
efficacy of serotonin-altering medications in this population
(Dykens and Shah 2003). Although altered serotonergic
functioning has long been implicated in autism, including
high levels of platelet serotonin (V eenstra-V anderweele et al.
2009), serotonin levels or serotonin-altering genes have yet
to be well-studied in PWS (although see Dykens et al. 2011).
The PWS/AS 15q11–q13 region is an epigenetic
“hotspot” for ASD susceptibility genes. PWS individuals
with mUPD are at higher risk for ASD due to the
duplication and overexpression of maternally expressed
genes in the 15q11–q13 region, including UBE3A (Schanen
2006; Wassink and Piven 2000). Persons with isodicentric
15 syndrome are also at high risk for autism and maternally
inherited duplications of the 15q11–q13 region are relative-
ly frequent in idiopathic autism, seen in 1–3% of these
cases (e.g., Bolton et al. 2001;V ortsman et al. 2006).
In a review of published studies on autism symptoms in
PWS or AS, V eltman et al. (2005) concluded that 38% of
children with PWS due to mUPD had co-occurring ASD
compared to 18% of PWS deletion cases and 2% of AS
cases. However, the pool of studies included in this review
was small (nine pertained to PWS, three to AS), and studies
also differed in sample size, participant ascertainment, and
the assessment tools used to make autism diagnoses.
Administering the Autism Screening Questionnaire to
parents of 63 offspring with PWS aged 4–48 years, V eltman
et al. (2005) found that 36.5% scored above the ASQ
criteria for ASD with 12.7% meeting more strict criteria for
autism. Although rates of autism did not differ across
genetic subtypes, those with mUPD versus deletions had
more autism symptoms, primarily in the social interaction
domain. Table 1 illustrates these symptoms in a brief case
example of a boy with PWS and ASD who was evaluated
in our research program.
Also relying on parent informants, Descheemaeker et al.
(2006) found that, compared to 59 controls with intellectual
disabilities (ID), 59 participants with PWS showed elevated
scores on the Pervasive Developmental Disorder–Mental
Retardation (PDDMR) questionnaire. Rates of pervasive
developmental disorder—not otherwise specified, however,
were similar across the ID and PWS groups (19% versus
15%, respectively). The PDDMR primarily assesses repet-
itive behavior, stereotypies, and restricted interests, with
few items pertaining to social impairments. Even so, those
with mUPD were significantly more likely to be rated as a
“loner among peers”, which hints at this group’s broader
social problems.
More rigorous diagnostic studies have been conducted in
AS. Peters et al. (2004) administered standardized autism
evaluations to 19 children with AS and found that 42% met
criteria for ASD on both the Autism Diagnostic Observa-
tion Schedule (ADOS) and Autism Diagnostic Interview,
Revised (ADI-R). These findings contrast with the low rate
of ASD in AS noted in V eltman et al. (2005), perhaps
because Peters et al. (2004) used well-accepted procedures
for making reliable ASD diagnoses. Subsequent studies
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ASD, but with a higher frequency (80%) in cases with
type 1 deletions (Sahoo et al. 2006).
In brief, studies to date across various 15q11–q13
syndromes indicate that autism spectrum disorders occur
in: the majority of persons with isodicentric 15 syndrome,
approximately 40% of those with PWS due to mUPD, 15–
18% of PWS cases due to deletions, and 40% of those with
AS, primarily those with type 1 deletions. Building on these
global diagnostic observations, research now needs to delve
deeper into specific autism symptoms in PWS and address
such questions as:
& Do infants with PWS show the same warning signs of
autism that are reliably established in young children
with idiopathic autism?
& What are the specific social, communicative, and
behavioral impairments in PWS that lead to suspicions
of autism in the first place?
& How do risk factors or clinical presentations of autism
in the 20% of paternal deletion cases compare to 40%
with mUPD?
& How do autism findings relate to the high rates of
psychosis, mood disorders, and severe psychiatric
illness in those with mUPD?
As discussed below, data that address these questions are
limited but have the potential to shed new light on the range
of phenotypic expression in both autism and PWS.
Features of autism in PWS
Studies on psychopathology in PWS primarily report
psychiatric diagnoses, yet these diagnoses are often
problematic. Diagnostic conventions and practices differ
across countries, disciplines, and classification systems,
with diagnostic criteria in PWS studies ranging from
International Classification of Diseases or Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition-
Revised to screeners, checklists, parent reports, and
symptoms in medical records. Due to their communicative
or cognitive delays, reliable psychiatric diagnoses are also
difficult to establish in people with intellectual disabilities,
including PWS (Dykens 2000). Studies are thus needed that
move beyond psychiatric diagnoses and provide detailed
characterizations of symptoms in PWS and the neural or
physiologic processes associated with these symptoms.
This need for more nuanced data becomes strikingly clear
in efforts to link PWS and ASD.
Autism spectrum disorders involve impairments in social
interaction, language and communication, and restricted,
repetitive, and stereotyped behaviors. Of these, impaired
social interactions are often considered central to the autism
diagnosis and phenotype. Ironically, social dysfunction is
not at all well-studied or understood in PWS. In contrast,
restricted and repetitive behaviors are seen in multiple
developmental disorders (Moss et al. 2009) and have been
carefully examined in PWS. As such, repetitive behaviors
as opposed to social concerns have served as the launching
pad for work linking autism and PWS.
Repetitive and restrictive behaviors
Types of compulsive behaviors Repetitive and restrictive
behaviors include highly frequent, inappropriate, and
invariant behaviors that are often seen in people with a
variety of intellectual and developmental disabilities.
Persons with ASD manifest both stereotypies and restric-
tive, repetitive behaviors (Lam and Aman 2007), while
those with PWS only occasionally have stereotypies and
instead show pronounced repetitive, compulsive behaviors
(Dykens et al. 1996; Clarke et al. 2002).
FrequentrepetitivebehaviorsinPWSareshowninTable 2,
based on 248 individuals with PWS aged 4–52 years who
have participated in our research program. These frequency
data were gleaned from the child and adult versions of the
Table 1 Case example of PWS mUPD and ASD
BN, a 7-year-old boy with PWS associated with mUPD, lives at home with his parents, three siblings, and attends a regular elementary school. BN
has low average cognitive abilities (FSIQ=86), good health, and has been on growth hormone treatment for several years. Relative to others
with PWS, BN has a low drive for food. His body mass index is in the average range. During his research visit, BN was extremely active and
asked incessant questions about staff and the assessment procedures.
Standardized questionnaires and parental interviews raised strong suspicions of autism, and BN met cut-off criteria for ASD on the Autism
Diagnostic Observation Schedule (ADOS Module 3); this diagnosis was confirmed after a review of his developmental and medical history. Key
features on BN’s ADOS included stereotyped language and inability for reciprocal conversation, lack of friends, side object gazing, hand and
finger mannerisms and unusual body posturing that increased when BN became excited. BN sniffed several test items and tended to ask the
same question again and again, or to repeat odd phrases, e.g., a list of children at school, “the most beautiful thing” in response to pictures in the
test materials. BN had to be redirected to complete many tasks and seemed to be easily distracted and overstimulated. He was somewhat
concrete but oriented to place, person, and time.
BN’s parents conveyed many concerns regarding his poor interactions with classmates and his school performance in general. BN became easily
overwhelmed with classroom activities and would either “shut down” or cry daily. Based on his ASD diagnosis, BN was assigned a classroom
aide and, with this support, is now doing considerably better at school.
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ifications to reflect PWS-specific concerns (e.g., skin
picking). The functionality of these compulsive symptoms is
not well understood and may vary within and across
individualswithPWS.Giventheirlesswell-developedinsight,
it is challenging to assess the extent to which compulsions in
PWS serve a similar anxiety reducing role as seen in patients
with classic obsessive–compulsive disorder (OCD). Some
behaviors (e.g., sorting through things) may bring enjoyment,
and stopping or preventing compulsive behaviors typically
leads to varying levels of distress. These behaviors appear
both internally driven and responsive to environmental
triggers and have been attributed to dysfunctional dopami-
nergic and serotonergic functioning (Dykens and Shah 2003).
As discussed below, severity of compulsions, as indexed by
time spent engaged in compulsions and symptom-related
distress and adaptive impairment, varies across age, intelli-
gence quotient (IQ), and PWS genetic subtype.
Beyond these compulsions, narrow interests are also
seen in people with PWS, and these are not limited to food.
In light of their hyperphagia and feeling “always hungry,
never full”, people with PWS are often preoccupied with
food seeking, eating, and their next meal. Food seeking,
however, lessens considerably once food sources are secured,
externally controlled, and meals are predictable and routine.
Importantly, people with PWS have a range of other, nonfood
interests and these are quite similar to those seen in autism
(e.g., movie or cartoon characters, trains, specific animals,
events). Unlike those with autism, individuals with PWS are
also quite likely to hoard objects or items that reflect these
narrow interests (e.g., pictures, menus, cards, movies, and
magazines) and typically know right away if others have tried
to clean or discard these items.
Comparative studies Using a parent informant measure, the
Childhood Routines Inventory, Greaves et al. (2006)
compared repetitive behavior in 80 children with PWS
versus 89 with ASD. The two groups had similar scores in
repetitive and “just right” domains, as well as in the
intensity and frequency of these behaviors. Children with
PWS were more apt to collect and store objects, while those
with ASD were more likely to line up objects and be aware
of such details as dust or flecks of dirt.
Moss et al. (2009) administered the Repetitive Behav-
ior Questionnaire to parents of offspring with seven
different genetic syndromes associated with IDD (Cru du
Chat, Smith–Magenis, Lowe, Cornelia de Lange, fragile
X, Angelman, and Prader–Willi syndromes). Relative to
other syndromic groups, those with PWS had a profile of
increased compulsivity, insistence on sameness, hoarding,
strong preference for routine, and low stereotypies.
Previous studies have also found increased compulsivity
in PWS relative to those with Smith–Magenis syndrome,
Down syndrome, and nonspecific intellectual disabilities
(Dykens and Kasari 1997), as well as to those with
intellectual disabilities matched on degree of obesity
(Clarke et al. 2002). Dykens et al. (1996) compared
Ya le –Brown Obsessive Compulsive Scale scores across 43
adults with PWS to 43 patients with obsessive–compulsive
disorder. The number and severity of compulsive behav-
iors were similar across groups, although those with PWS
were more likely to hoard, while those with OCD were
more likely to check.
Correlates of compulsivity Correlates of repetitive, com-
pulsive behaviors in PWS have also been identified. Gender
differences, for example, are not generally found in these
behaviors, although increased severity of compulsive
symptoms have occasionally been reported in males (Clarke
et al. 2002; Dykens et al. 1996). Level of IQ is negatively
correlated with repetitive behaviors in PWS, such that those
with lower IQs show more pronounced compulsivity, a
finding also seen in those with intellectual disabilities in
general (Dykens et al. 1996; Clarke et al. 2002; Holland et
al. 2003).
Data are contradictory regarding the role that PWS
geneticsubtypesplayinrepetitive,compulsive-likebehaviors.
Aside from somewhat lower skin picking in mUPD cases
(Symons et al. 1999; Dykens and Roof 2008), researchers
report inconsistent differences in repetitive behavior across
genetic subtypes. Some groups find more cleaning and
redoing compulsions (and lower adaptive and academic
skills) in people with type I deletions (Butler et al. 2004;
Hartley et al. 2005, Zarcone et al. 2007), while other do not
(Milner et al. 2005; V arela et al. 2005). Inconsistent findings
may be due to small sample sizes (e.g., Butler et al. 2004;
deletion, n=24) and the diverse age ranges of participants.
Table 2 Frequency of repetitive, compulsive-like behaviors in 248
individuals with Prader–Will syndrome
Compulsive-like behaviors (%)
Skin picking 80






Fearful losing things 29
Repeated checking 24




Pulls hair out 13
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mUPD cases, Dykens and Roof (2008) found behavioral
differences across genetic subtypes only in relation to age.
Age-related increases were seen in obsessional thinking and
hoarding in those with mUPD, which is consistent with their
vulnerabilities to psychiatric illnesses in young adulthood. In
those with type II deletions, no relations were found between
age and compulsive or other behaviors. In contrast to both of
these genetic subtypes, those with type I deletions showed
consistent, negative associations between age and compul-
sivity, externalizing problems, adaptive behavior skills, and
hyperphagia. In essence, although their problem behaviors
appear to mellow over time, they may also show less
engagement and activities in general.
It is unknown why the group with type I deletions
showed age-related mellowing, but a reasonable explana-
tion involves those genes that are deleted in type I
individuals but present in others with PWS. Of these,
CYFIP1 is of particular interest, as it has been linked to
other 15q11–q13 disorders and to an unusual variant of
fragile X syndrome. CYFIP1 is a primary target of fragile X
mental retardation protein (FMRP), the protein involved in
fragile X syndrome, and likely enables FMRP to carry out
its functions in transporting and regulating mRNAs (Chai et
al. 2003). Nishimura et al. (2007) reported that CYFIP1
was selectively over-expressed in cases with maternal
duplications of 15q11–q13 and autism. As excess CYFIP1
was also found in fragile X cases and autism, Nishimura et
al. (2007) propose that CYFIP1 is a common molecular link
between co-occurring fragile X syndrome and ASD, and
15q duplications and ASD. Using a different cohort,
Nowicki et al. (2007) found altered CYFIP1 in 13
individuals with fragile X syndrome and a Prader–Willi
phenotype. These atypical cases had fragile X mutations,
along with obesity, hyperphagia, compulsivity, symptoms of
ASD, and other sporadic PWS features. Compared to a
group with classic fragile X syndrome or typical controls,
these fragile X–PWS phenotype cases had reduced levels of
CYFIP1 mRNA. Additional studies are needed on the role
that CYFIP1 and other non-imprinted genes play in the
expression and trajectory of compulsivity and other
behaviors in PWS.
Self-injurious behaviors Self-injurious behaviors (SIBs) are
often studied alongside repetitive behaviors and stereoty-
pies. Although people with PWS or autism have high rates
of SIBs, research has not directly compared the types,
topologies, or severity of SIBs across these two disorders.
The majority of those with PWS (75–85%) engage in skin
picking (Dykens et al. 1999; Symons et al. 1999) and in
some individuals picking may lead to recurring infections
and serious medical complications. Rectal picking also
occurs in about 20%, though this may be an underestimate
as parents or individuals are reluctant to spontaneously
report this behavior (Dykens, unpublished data). Skin
picking may lessen with age, is not related to IQ, and is
slightly less common in those with mUPD. Neither
behavioral nor pharmacological treatments have succeeded
in consistently reducing skin picking in PWS.
In contrast, those with ASD show more diverse forms of
SIBs (e.g., biting and head banging); and compared to
others with intellectual or developmental disabilities, those
with autism invariably show more frequent and severe SIBs
(e.g., Bodfish et al. 2000; Oliver and Richards 2010). SIBs
in autism are inversely related to IQ and may lessen with
age, and other features of SIBs have also recently been
identified. Relating repetitive behaviors and SIBs in
children with autism to their levels of whole blood
serotonin, Kolevzon et al. (2010) found an inverse relation
between serotonin and SIBs but not to repetitive behaviors.
The specificity of serotonin to SIBs is interesting, as
previous studies have not generally found associations
between plasma serotonin and behavioral functioning in
autism (see V eenstra-V anderWeele et al. 2009). Focusing on
adults, Cohen et al. (2010) found that men with autism were
more likely to exhibit aggression aimed at others, while
women with autism were much more likely to engage in
SIBs. Given the preponderance of males with autism,
females are less likely to be studied, and apparent gender
differences in SIBs underscore the need for more research
with females on the autism spectrum.
In brief, PWS and ASD involve both similarities and
differences in their profiles of characteristic repetitive and
self-injurious behaviors. Even against a shared backdrop of
insistence on sameness, repetitive questioning, and narrow
interests, PWS is distinguished by hoarding and skin
picking, and autism by stereotypies and more diverse and
severe SIBs. Further research is needed on the underlying
neurobiology of these behaviors in both PWS and autism,
and on behavioral or pharmacological treatments that
address these salient problems.
Social and communicative impairment
Although many persons with PWS have problems getting
along with others, data are scant on social impairment,
which is unfortunate given the central role that social
dysfunction plays in autism. Compared to age-matched
persons with Williams or Down syndromes, those with
PWS have similar socialization scores on the Vineland
Adaptive Behavior Scales. They also have the same
numbers of friends but they see these friends less often,
are less competent with them, and experience more social
problems in general (Dykens and Kasari 1997; Rosner et al.
2004). Further, socially competent behaviors in PWS do not
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these competencies contrast with age-related gains in both
Williams and Down syndromes (Rosner et al. 2004). While
these data depict social problems, they do not address
specific impairments that constitute the hallmark of autism in
face processing, social cognition, or communication.
Aberrant face processing has been identified in people
with ASD using eye tracking, event-related potentials
(ERPs), and functional neuroimaging. Eye tracking studies,
for example, show that children with ASD often demon-
strate less fixation on eyes and/or they have a relative
proficiency in processing the mouth region relative to the
eye region (Dalton et al. 2005; Klin et al. 2002). Studies are
now underway using eye tracking in PWS. In ERP work,
the N170 is often used as an electrophysiological marker
for the encoding of upright faces and children with autism
appear to have a dampening of the N170 in response when
viewing faces (Grice et al. 2005). A preliminary study in
PWS found a similar dampening effect in eight individuals
with paternal deletions (Halit et al. 2011). The eight
participants with mUPD showed a more typical N170
response to faces, but their eye gaze processing was similar
to adults with autism. Data suggest unusual perceptual
processing of faces in both genetic subtypes of PWS.
At least 200 neuroimaging studies have examined aspects
of face or emotional processing in people with autism or those
atriskforASD,includingsiblings.Kaiseretal.(2010) recently
placed this literature into a broader conceptual framework of
disrupted neural states, traits, and compensatory activities in
persons with autism and their unaffected siblings. In contrast,
no fMRI studies have been published of face processing in
PWS. The five fMRI studies published to date in PWS have
all examined various aspects of food processing, reward
circuits, and satiety. Findings show marked delays in satiety
and aberrant post-meal activation of circuits involved in
hunger (see Dimitropoulos and Schultz 2008).
Beyond face processing, data are also scant on other
aspects of social cognition in PWS. Tager-Flusberg and
Sullivan (2000) found that children with PWS fared as well
if not better than children with Williams syndrome or other
disabilities in theory of mind tasks tapping false beliefs,
social actions, and emotional recognition. Difficulties in
PWS may arise, however, when tasks require an appreci-
ation for more complex or abstract mental states. Using a
social attribution task involving ambiguous stimuli (moving
shapes in a video), Koenig et al. (2004) report that those
with PWS performed as poorly as those with ASD and
below IQ-matched controls without ASD. Participants with
PWS made simple cognitive attributions about the moving
shapes but were less able to make inferences about affective
states related to the scenario (e.g., envy, admiration, and
appreciation). They thus failed to attend to pertinent details
and produce a coherent social story.
Additional research is clearly needed on social function-
ing in PWS, especially work that uses similar neural and
behavioral methodologies as the autism literature. The lack
of detailed data on social or communicative functioning in
PWS limits its usefulness as a genetic model for autism,
and, on a practical level, it muddies the intervention waters
considerably. As autism can be identified at increasingly
young ages (12–18 months), with most children optimally
diagnosed by age 3, studies are especially needed on social
and communicative development in infants with PWS.
Infants and young children with PWS
Infants with PWS or ASD demonstrate developmental
delays, as well as gradual changes over time in tempera-
ment, emotional regulation, and difficulties in shifting
attention from food or other perseverative interests. A rich
literature exists on young children suspected of having
autism or who are at high risk for ASD given their sibling
and familial status. This body of research has identified the
sensitivity and specificity of several autism screening tools
for young children, standards for best practices in making
autism diagnoses in young children, the nuances of social,
cognitive, and motor developments and the efficacy of
different models of early intervention (see Zwaigenbaum
2010 for a review). In contrast, infants with PWS have not
been studied through the same careful developmental lens,
and major gaps in knowledge exist on early social and
communicative functioning and indices of autism in these
children. Table 3 compares key features in infants with
PWS versus autism.
Infants with PWS are hypotonic, lethargic, have difficulty
sucking, and often need to be awakened for feedings; one
feedingcanliterallytakehours.ChildrenandadultswithPWS
also have well-documented growth hormone deficiency and
growth hormone treatment is now an Food and Drug
Administration-approved best practice in the management of
infants and children (see Miller et al. 2006 for guidelines).
The benefits of growth hormone therapy (GHT) are well-
established and include reduced body fat and increased lean
muscle mass, linear growth, agility, muscle strength, coordi-
nation, and exercise tolerance; a softening of the classic PWS
facial features and in toddlers, earlier ages of walking
independently (Carrel et al. 1999; Myers et al. 2007).
Anecdotally, parents report that their children on GHT
are more alert, energetic, attentive, and cooperative (Carrel
et al. 1999), which may lead to increased learning
opportunities. Indeed, compared to untreated controls,
growth hormone-treated infants tested 1 year apart showed
greater gains in language, cognition, and motor functioning
(Festen et al. 2008; Myers et al. 2007). It is unclear if such
gains in infants or toddlers are sustained over the course of
development.
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primarily evaluated the effects of GHT, and in years past,
described their failure to thrive, metabolic rates, body fat,
and delayed motor and language milestones. Unlike infants
with ASDs, studies have not identified trajectories of social
or communicative development in infants with PWS.
Clinical lore suggests that infants with PWS are pleasant,
cooperative, and friendly (Cassidy et al. 2000). After this
period of apparent social responsiveness, they develop
notable behavior problems, including temper tantrums,
stubbornness, skin picking, and eventually food seeking
(Dimitropoulos et al. 2001). No data have been published
that specify early social and communicative deficits in
children with PWS in eye gaze, shared positive affect, and
social gestures such as pointing, joint attention and
orientation to name. Prospective studies are needed that
examine these key indices of social–communicative func-
tioning, including factors that discriminate infants with
PWS from those who are later diagnosed with ASD.
Associated features of autism or PWS
Salient associated features in autism or PWS include co-
occurring psychiatric disorders, concerns with food and
obesity, difficulties with sleep, and apparent strengths in
visual–spatial functioning. Although not exhaustive, these
features are relatively well-studied within each disorder and
suggest several intriguing avenues for future research that
directly compares groups with PWS versus ASD.
Psychiatric disorders
Psychiatric studies in PWS have relied solely on diagnostic
labels, leaving specific psychiatric symptoms unclear or
poorly described. Examining PWS cases that screened
positive for psychopathology, Soni et al. (2007) report that
affective illness was more prevalent in mUPD versus
deletion cases (64% as opposed 28%). Further, they note
that more severe psychiatric presentations, including bipo-
lar illness and psychosis with or without depression, were
only seen in those with mUPD. In contrast, Descheemaeker
et al. (2002) followed 52 adults with PWS; and of the eight
with psychiatric diagnoses, “bipolar affective disorders”
were only reported in those with paternal deletions.
Examining 33 cases with mUPD, aged 5–36 years (M=
19 years), we found that they were more than twice as
likely as their counterparts with deletions to have been
psychiatrically hospitalized (55% versus 20%; Dykens and
Roof 2008). Unlike those with deletions, our mUPD sample
also manifested significant, age-related increases in thought
problems, noncompliant behavior, obsessions, and hoard-
ing. These findings are consistent with previous reports of
age-related increases in psychopathologies in this genetic
subtype. A case example of a young adult with mUPD and
co-occurring psychosis is presented in Table 4.
Explanations for high rates of psychosis in mUPD
generally implicate increased expression of maternally
imprinted genes, especially UBE3A. Recently, however,
gamma-aminobutyric acid receptor genes located in the
PWS 15q11–q13 region have also been implicated; these
genes are receptors for the brain’s primary inhibitory
neurotransmitter. Sharp et al. (2010) recently identified a
novel differentially methylated regions (DMR) in the PWS
critical region that was distal to gamma-aminobutyric acid A
receptor-γ3 (GABRG3). Webb et al. (2008) previously
identified this same region as conferring increased risks of
psychosis in adults with PWS due to mUPD, but not paternal
deletion. While other DMRs in the 15q11–q13 region
showed complete maternal or paternal methylation, this
GABRG3 region was only partially methylated, suggesting
that imprinting at this site is weakly regulated (Sharp et al.
2010). Relatively weaker parent of origin expression may
help explain previous conflicting reports about methylation
at the GABRG3 site. Sharp et al. (2010) hypothesize that this
DMR represents a promising candidate locus, or genetic or
epigenetic variation that confers risks for psychosis in PWS,
and future work may suggest ties to autism as well.
If the majority of people with mUPD develop psychosis or
severe affective illness by late adolescence or early adulthood
Table 3 Characteristics of infants and young children with PWS or
autism spectrum disorders
PWS Idiopathic Autism
Failure to thrive + ±
Poor suck, feeding + ±
Central hypotonia + ±
Motor delays
a +±
Developmental regression − ±
Impaired social communication
b Limited data +
Repetitive interests, behaviors
c ++
Delays in play skills
d Limited data +
(+) indicates a consistently seen feature, (−) indicates that the feature
is not generally present, (±) indicates that the feature is variably
present or not consistently found
aMotor delays are less pronounced in PWS infants receiving growth
hormone therapy
bSocial communication impairment includes: atypical eye gaze,
orienting to name, social smiling, and social interest and affect, with
reduced expression of positive emotion
cRepetitive behaviors encompass atypical exploration of toys or
objects, including prolonged visual examination, unusually repetitive
actions
dDelays in play skills include motor imitation and functional use of
toys (summarized in Zwaigenbaum, 2010 for infants aged 12–
18 months)
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mUPD may provide an extremely useful window into
psychosis in the general population. However, the specific
symptoms associated with psychosis in PWS have yet to be
well-described, leaving it unknown if these episodes are
characterized by visual or auditory hallucinations, cognitive
distortions, magical thinking, paranoia, severe or unusual
obsessions, or by withdrawal, irritability, oppositionality, and
changes in sleep, appetite, or activity levels.
Using a retrospective record review of adults with mUPD
and psychosis, V ogels et al. (2003) noted that most had
symptoms of autism or autism diagnoses as children. This
finding is puzzling, as data on secondary psychiatric
conditions in people with ASD consistently find increased
rates of depression and anxiety disorders, but substantially
less overlap with psychosis or schizophrenia (Joshi et al.
2010; Leyfer et al. 2006; Tasatsanis 2003). Based on a
psychopharmacology clinic sample of children and adoles-
cents, Joshi et al. (2010) found that 61% of 217 patients with
ASDs had multiple anxiety disorders, 83% had attention
deficit hyperactivity disorder (ADHD), and 20% had
psychosis. These rates were significantly higher than non-
ASD clinic patients and confirm earlier reports of elevated
ADHD, anxiety and affective disorders, but not psychosis, in
persons with ASD (Leyfer et al. 2006). The 20% of ASD
patients with psychosis in the Joshi et al. (2010) study were
not further described. If psychosis is indeed rare in autism,
then comorbidities of both autism and psychosis in PWS is
quite discrepant with the general ASD population.
It is not clear how to best reconcile research indicating
high rates of both autism and psychosis in PWS. Some
suggest an apparent “evolution” from autism in childhood
to psychosis in adulthood (Descheemaeker et al. 2002).
Others assert that autism diagnoses in neurodevelopmental
disorders with strong associations to schizophrenia, such as
22q deletion syndrome or Klineflelter’s syndrome, are
actually false positives (e.g., Eliez 2007). In this view,
autism diagnoses are an unsuccessful or superficial effort to
capture premorbid personality or social dysfunction or what
is essentially a prodromal state on the road to psychosis.
Still others hypothesize that autism and psychosis are
diametric disorders in their clinical phenotypes, and genetic
and neural underpinnings (Crespi and Badcock 2008).
Crespi (2008) used disruptions in maternal imprinting and
proneness to autism in AS versus disrupted paternal
imprinting and proneness to psychosis in PWS to support
the conflict theory of imprinting in evolutionary biology.
However, none of these possible explanations can be
properly evaluated without detailed data on aberrant social,
cognitive, or emotional processes in PWS. Categorical
diagnoses of autism or psychosis are inadequate, and more
fine-tuned and nuanced phenotypic descriptions in PWS are
needed in order to address these hypotheses. An unclear
symptom picture in PWS also severely limits treatment. If
up to 40% of those with mUPD and 20% with deletions
indeed develop autism, then they may benefit from early
interventions that help children with autism in general. If
the majority of persons with mUPD develop psychosis,
then treatment can also move to a prevention mode, perhaps
minimizing disease course via pharmacotherapy, behavior-
al, or other interventions. Preventative measures, however,
first require identification of the symptoms being targeted
and when they emerge or worsen.
Food and obesity
Although hyperphagia in PWS stands out, the drive for
food in affected individuals is actually quite nuanced.
Table 4 Case example of PWS mUPD and psychosis
JJ, a 21-year-old male with PWS due to mUPD, lives at home with his parents and attends a vocational day program. He is healthy following a
weight loss of 103 lb at age 17 that occurred during and after a stay in an in-patient hospital specializing in PWS. At the time of his follow-up
research visit, JJ weighed 136 lb, was 5 ft tall, and taking antipsychotic medications. His parents were diligent with his diet and locking food. JJ
was quite proud of his weight loss and tended to open conversations with, “I lost 103 lb, are you proud of me?”
JJ’s parents reported increased agitation and aggressive behavior aimed at both them and his program staff (e.g., hitting, pushing, verbal threats).
He was emotionally labile, laughing, for example, over something funny “in my head” and then within seconds being verbally abusive. At age
14 JJ experienced auditory and visual hallucinations, including an episode when his parents found him sitting naked on a couch outside their
bedroom door, seeing and talking to make believe cartoon characters. He was subsequently placed on anti-psychotic medications but continued
to have looseness of thoughts and magical thinking.
During his visit to the lab, JJ hit the staff and then demanded that they repeat the phrase “No, I did not hit you”, and he became enraged when they
did not exactly comply. JJ’s speech was repetitious, nasal, pressured and perseverative, and sprinkled with demands that the staff repeat phrases
verbatim that were unrelated to context, e.g., “Yes, that really looks like blue green.” JJ believed that others could know what he was thinking
even if he did not say it aloud and he became angry when the staff would not acknowledge his powers and believed that they were making fun
of him. He was not oriented to person or place and insisted on eating lunch at his favorite restaurant some 600 miles away.
JJ’s cognitive level (FSIQ=41) had declined dramatically since his first psychotic episode at age 14 when he was functioning in the borderline range
(FSIQ=77). His parents were quite concerned that his escalating and bizarre behavior would not allow him to continue in the vocational day program
and they feared that they would need to quit working in order to take care of him. The research team referred JJ to a PWS residential program for
evaluation and possible placement as his escalating behaviors and thought disturbances required a more intensive treatment approach.
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(failure to thrive followed by onset of hyperphagia in early
childhood), PWS is comprised of up to seven distinct
nutritional stages and transitional periods that reflect
different phases of food intake, underlying neuroendocrine
status, and degree of obesity (Miller et al. 2011). Full-
blown hyperphagia varies in length and also waxes and
wanes in severity (Dykens et al. 2007). People with PWS
rarely vomit or report gastrointestinal (GI) distress, yet
these relatively benign complaints in most people can
signal a life-threatening emergency in PWS related to acute
gastric dilation, perforation, necrosis, and death (Stevenson
et al. 2007). Higher risks of gastric dilation and rupture are
seen in individuals with rapid weight loss or who are
generally slim but have a binge-eating episode.
In contrast to hyperphagia in PWS, approximately 23%
of children and adolescents with ASD have food selectivity,
including food refusal, a limited food repertoire, and high
frequency of eating single foods (Bandini et al. 2010). Food
selectivity in ASD may relate to GI distress, including
constipation, encopresis, and diarrhea, seen in approximately
25% of children with this disorder (e.g., Joshi et al. 2010;
Nikolov et al. 2009). Recent data implicate associations
between the MET C polymorphism and GI symptoms in
children with ASD as well as associations between MET C
and social and communicative symptoms but only in those
with GI difficulties (Campbell et al. 2009).
Relative to the general population, children and adoles-
cents with ASD are more likely to be obese or overweight.
Compared to typical 10–17 year olds, Chen et al. (2010)
found much higher rates of obesity in children with autism
(12.2% versus 23.4%, respectively). Among adults, Eaves
and Ho (2008) report that 42% were overweight or obese.
Risk factors for obesity in ASD are similar to those seen in
other disability groups, including a sedentary lifestyle, lack
of regular activities or exercise, not being able to readily
access gyms or recreational sports, limited knowledge
about nutrition or healthy food choices, and appetite-
altering side effects of psychotropic medications. Although
obesity is increasingly identified in ASD, few evidence-
based, weight-reduction programs exist that take into
account the unique aspects of ASD.
Complications of obesity are the leading causes of
premature death in adults with PWS (e.g., Einfeld et al.
2006); and obesity in this syndrome is related to mental
health in complicated ways. In the general population,
being overweight or obese is often associated with low self-
esteem, and losing weight and being fit and trim with
improved esteem (e.g., Simon et al. 2006). People with
PWS, however, seem to show the opposite pattern.
Specifically, adolescents and adults with lower body mass
indices have increased compulsive behaviors, hoarding, and
withdrawal, and are also more nervous, tense, tearful,
distressed, upset, agitated, and cognitively disorganized
(Dykens 2004; Hartley et al. 2005).
Although reasons for these counterintuitive finding are
unknown, they may be associated with the effort, and
physiological and psychological stress, of maintaining a
lower weight. Due to their hypotonia and low-resting
metabolic rate, persons with PWS typically require fewer
calories than others to lose or maintain weight. Chronic,
very low caloric restrictions (800–1,200 k/cal daily) or
sudden weight loss may contribute to increased distress,
disorganization, or compulsivity, perhaps more so in those
already at risk due to mUPD. Simply put, the lifelong
experience of being “always hungry, never full” may lead to
more distress when access to food is curbed and weight loss
or maintenance is achieved. Future studies using bio-
markers of stress could shed some light on these hypotheses
and inform decisions about balancing dietary restrictions
with quality of life in persons with PWS and their families.
Sleep
Sleep disturbances occur in the majority of children with
autism,especiallysleep-onsetinsomnia,nocturnalawakening,
and shorter overall nighttime sleep duration (Goldman et al.
2009). Examining sleep in a large cohort of children with
ASD, Goldman et al. (2009) found that poor sleepers, as
determined by polysomnography, actigraphy, and parent
report, had more daytime behavior problems, primarily
hyperactivity and repetitive behaviors, than those deemed
good sleepers. Further, actigraphic measures of wakefulness
after sleep onset and sleep fragmentation were correlated
with hyperactivity and restrictive and repetitive behaviors.
Aberrant sleep in PWS is well-described, including high
rates of central and obstructive sleep apnea, abnormal
arousal, abnormal circadian rhythm in rapid eye movement
(REM) sleep, night awakenings, and excessive daytime
sleepiness (Maas et al. 2010; Yee et al. 2007). Obesity may
worsen some of these sleep parameters, yet does not
completely explain abnormal REM or excessive daytime
sleepiness, which are likely related to hypothalamic
dysfunction (Bruni et al. 2010). Indeed, excessive daytime
sleepiness can be quite impairing for individuals, regardless
of their weight. Although disrupted sleep is associated with
behavior problems in people with autism and intellectual
disabilities in general (see Richdale and Schreck 2009 for a
review), such relations are not readily apparent in PWS
(e.g., Maas et al. 2010).
Beyond behavior problems, compelling evidence from
both clinical and typical populations link sleep duration and
quality to specific aspects of memory and cognition (see
Durmer and Dinges 2005 for a review). Even so,
researchers have yet to examine relations between sleep
and cognition in PWS, autism, or other disability groups.
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(e.g., Bruni et al. 2007), a known risk factor for cognitive
deficits, which further highlights the need for research on
cognition, sleep, behavior, and mood in this syndrome.
Visual–spatial strengths
Relative to their verbal skills, persons with autism appear to
have strengths in visual–spatial processing. Earlier work
found that people with ASD performed relatively well on
standardized tasks assessing visual–spatial and pattern
recognition, including block design, object assembly, or
the imbedded figures test. More recent studies have fine-
tuned these observations, pointing, for example, to intact or
enhanced performance on static visual features or patterns,
and inferior performance on more complex and dynamic
spatial memory tasks (Bertone et al. 2005).
Persons with PWS have a similar profile. Early studies
indicated relative strengths in visual–spatial functioning on
standardized IQ tasks (e.g., block design), and individuals
with PWS were also rumored to excel at jigsaw puzzles
(Holm et al. 1993). Compared to others with intellectual
disabilities, those with PWS spend more time engaged with
puzzles (Dykens and Rosner 1999), and they also far
outperform both IQ- and age-matched controls on jigsaw
puzzles (Dykens 2002). Interestingly, they have only
modest relative strengths in standardized visual spatial
tasks. V erdine et al. (2008) administered puzzles and tasks
tapping spatial perception, mental rotation, and spatial
visualization to a sample with PWS- and MA-matched
controls. Although the PWS group performed relatively
poorly on the spatial tasks, they performed very well on
interlocking jigsaw puzzles, including achromatic puzzles.
The typical control group used a visual approach to puzzle
solving, while those with PWS had a pronounced, shape-
based approach. Persons with autism are also rumored to
excel at jigsaw puzzles, and a competency with puzzles is
one of several specialized interests tapped in the ADI-R.
Even so, researchers have yet to formally assess puzzle
skills in this population and how they relate to broader
visual–spatial functioning.
Next steps for research
Although far from exhaustive, this review highlights
phenotypic similarities and differences across PWS and
ASD, as well as salient knowledge gaps that need to be
addressed in future research. These gaps are reflected in
Table 5, which summarizes areas of phenotypic overlap and
difference addressed in this review. Importantly, as few
studies have directly compared participants with PWS or
ASD, many features in Table 5 are “best guess” hypotheses
based on findings within each disorder.
Future comparative studies are needed that take several
methodological considerations into account. First, researchers
need to use such gold standard tools for assessing autism in
PWS as the ADOS-R and the ADI-R. Even so, these brief,
interview-based assessments may not necessarily capture
features of PWS that could discriminate between PWS and
ASD. Consistent with best practices, then, researchers need to
carefully review ADOS scores along with other behavioral,
developmental, and medical data in making autism diagnoses
in PWS and other genetic disorders.
A second issue pertains to comparison groups. Depend-
ing on the questions under study, various combinations of
groups could be compared including individuals with PWS
who do versus do not have autism diagnoses and who are
Table 5 Hypothesized similarities and differences in core symptoms
and associated features of ASD and PWS
PWS ASD
Repetitive behaviors + +
Symmetry/exactness + +
Narrow interests (not food) ± ±
Skin picking + Limited data
Hoarding + Limited data
Need for sameness + +
V erbal perseveration + +
Stereotypies − ±
Self-injury (not skin picking) − ±
Poor peer relations + +
Impaired theory of mind Limited data ±
Poor emotional recognition Limited data ±
Aberrant face processing Limited data +
Problems reading social cues Limited data +
Psychosis ± Limited data
Positive symptoms ± Limited data
Negative symptoms + Limited data
Anxiety disorders + +
Depressive disorders ± ±
Excessive daytime sleepiness + −
Sleep-onset insomnia − ±
Nocturnal awakening ± ±
Obstructive sleep apnea ± −
Obesity ± ±
Hyperphagia + −
Food preoccupations ± −
Limited food selectivity − ±
Eating/food rituals ± ±
Cognitive deficits + ±
Facility w/jigsaw puzzles ± Limited data
(+) indicates a consistently seen feature, (−) indicates a feature that is
not generally present, (±) indicates a feature that is variably present or
more inconsistently found
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disorders or other intellectual disabilities. While these
groups help distinguish features seen in PWS versus
autism, a more nuanced approach uses comparison groups
that selectively target the constructs under study. The type
or severity of compulsive behaviors, for example, could be
variably compared across people with PWS, PWS plus
ASD, ASD, obsessive–compulsive disorder, and subtypes
of patients with OCD (e.g., hoarders). Social–cognitive
deficits could be compared across individuals with PWS,
autism, schizophrenia, and atypical psychosis including the
neurobiological underpinnings of these impairments (see
Sasson et al. 2011). By studying “endophenotypes”, these
approaches emphasize neural, genetic, hormonal, psycho-
physiological, or developmental processes that are shared
or distinctive to these disparate conditions.
Finally, gaps in knowledge need to be filled in with an eye
toward clinical relevance. Careful descriptions of aberrant
social, cognitive, and neural processes are needed for future
research that aims to identify how the expression of
susceptibility genes in the PWS/AS region (e.g., UBE3A,
snoRNAs,andGABRG3) contributes toautism, psychosis,or
other challenges. These behavioral and neural discoveries are
needed to make more informed and immediate decisions
about intervention. For example, should pharmacotherapy or
other treatments begin as soon as adolescents with PWS show
even a slight worsening or subtle onset of problems in
thinking or mood? What other risk or protective factors
derived from the autism, schizophrenia, or intellectual
disabilities literature could inform treatment in PWS? Con-
versely, how does PWS inform genetic and other risks for
autismorpsychosis inthegeneralpopulation? AlthoughPWS
has not been as rigorously studied as other genetic conditions
associated with autism or psychosis, it holds considerable
promiseforsheddingnewlightonmechanismsandtreatments
for these otherwise debilitating disorders.
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